ESTRO35 Programme Book

11:05 > Modelling of secondary cancer risks Speaker: U. Schneider (Switzerland)

SP-0437

11:25 > Clinical implications of secondary cancer risks in pediatric and adult patients Speaker: D. Hodgson (Canada)

MONDAY 2 MAY 2016

SP-0438

Proffered Papers RADIOBIOLOGY 4: MOLECULAR BIOMARKERS FOR PATIENT SELECTION

10:45 - 11:45 | LONDRA Chair: C. West (UK) Chair: M. De Jong (The Netherlands)

10:45 > Localization of p16 expression is an important factor to determine radiotherapy response in HNSCC R. Dok (Belgium), L. Abbasi Asbagh, E. Van Limbergen, A. Sablina, S. Nuyts 10:55 > Impact of chemokine receptor CXCR4 and its ligand SDF1 expression on loco-regional control in HNSCC A. Menegakis (Germany), C. De Colle, D. Moennich, F. Fend, P.S. Mauz, S. Welz, I. Tinhofer, V. Budach, E. Gkika, M. Stuschke, P. Balermpas, C. Roedel, M. Avlar, A.L. Grosu, A. Abdollahi, J. Debus, C. Bayer, C. Belka, S. Pigorsch, S.E. Combs, M. Krause, M. Baumann, D. Zips 11:05 > Genomic amplification of FancA in HNSCC: mechanisms of radioresis- tance and clinical relevance 11:15 > Does miR-210 predict benefit from hypoxia modification in BCON randomised bladder cancer patients? C. West (UK), J. Irlam-Jones, A. Eustance, H. Denley, P. Hoskin, A. Choudhury 11:25 > Radiotherapy sensitivity in breast cancer is influenced by the DNA cyto- sine deaminase APOBEC3B P.N. Span (The Netherlands), A. Post, J.W.M. Martens, R.S. Harris J. Hess (Germany), I. Gimenez Aznar, A. Michna, D. Klein, U. Schötz, M. Orth, L. Schneider, H. Braselmann, L. Schüttrumpf, V. Jendrossek, C. Belka, V. Zangen, K. Unger, H. Zitzelsberger, K. Lauber

OC-0439

OC-0440

OC-0441

OC-0442

OC-0443

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

128